TRCB1 (T cell Receptor C Beta 1) is proving to be an increasingly useful cell surface marker in identification of T cell subsets and T cell malignancies
“Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms” H Berg, H Olteanu, et al. (May 2021) Clinical Cytometry 100(3): 361-369. https://doi.org/10.1002/cyto.b.21881 Ancell anti-human TRCB1 (Clone JOVI-1) reagents: 101-020 Purified (with Preservative) 101-820 Purified […]